Ivermectin approved to treat Covid-19 on limited basis - SA medicines regulator

Ivermectin has been approved for use in treating Covid-19 in South Africa on a limited basis. This follows an urgent court application by lobby group Afriforum to force the regulatory authority to allow the use of the drug most commonly used for treating parasites in animals in the country for human use. First, you will hear Professor Helen Rees, chair of the SA Health Products Regulatory Authority (Sahpra) board, explain why the regulator cannot give full registration to the drug for human use in relation to Covid-19. Sahpra CEO Boitumelo Semete-Makokotlela sets out more detail on how access to the drug will work and next steps as a university works on approval for a human trial on the use of Ivermectin to treat Covid-19. They were speaking to journalists at the Pretoria Press Club. Learn more about your ad choices. Visit megaphone.fm/adchoices